This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Advanced Ovarian Cancer - PRIMA Trial

442 views
September 19, 2024
Comments 0
Login to view comments. Click here to Login